Episoft OC is made by pharmaceutical giant Glenmark Pharmaceuticals. It is specifically formulated non-drying cleansing gel which keeps skin oil-free without any breakouts. Episoft OC Cleansing Gel is a clinically tested and dermatologically proven safe cleansing gel. Episoft OC gel is formulated for use for a wide range of skin types from combination to oily skin. It cleanses the face of impurities and maintains safe neutral pH, low pH levels.
Episoft OC Gel adds softness to the skin and makes the skin supple. The cleansing action also controls the sebum secretion from the pores. Episoft OC cleanses the skin for softer, smoother and younger-looking skin, maintains the Safe pH level of the skin between 5.5-6, keeps the skin soft and supple, reduces sebum secretion, cleanses without clogging skin pores, suitable for all skin types, especially oily skin, non-comedogenic and dermatologically safe.
BENEFITS OF EPISOFT OC FACIAL SKIN CLEANSING GEL
Helps reduce skin blemishes;
Gently cleanses the skin;
Soothes and moisturizes;
Gentle soap-free formula suitable for all skin types.
HOW TO USE EPISOFT OC FACIAL SKIN CLEANSING GEL
Wet your face with water;
Apply and rub the gel to the face or affected area;
Massage for a minute and wash with clean water;
Use twice a day in the morning and evening;
Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 100 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2012). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis, etc.] and Pain [neuropathic pain and inflammatory pain]. The company has a significant presence in branded generics markets across emerging economies including India. GPL along with its subsidiary has 14 manufacturing facilities in four countries and has six R&D centers spread across India, UK, and Switzerland. It's subsidiary, Glenmark Generics Limited services the requirements of the US and Western Europe generics markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India. Glenmark was founded with a vision to emerge as a leading integrated research-based, a global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). We have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 80 countries including the US, various countries in the EU, South America and India. With 17 manufacturing facilities and 5 R&D centers dedicated to the goal of enriching lives across the globe we believe that the real force behind our continued successes are dedicated employees from across 50 nationalities, committed to creating 'A new way for a new world'.